Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > My Call NOT Returned
View:
Post by toade1313 on Mar 03, 2022 6:48pm

My Call NOT Returned

Yesterday morning I called the Theralase office and per the instructions I left my name and number. Now 2 days later still no return of my call. Has anyone else had luck reaching a person at the office and getting any comments on how/when test results will be communicated to shareholders?
Comment by Toad09 on Mar 03, 2022 7:12pm
No they don't comment back to msg's especially ones involving shareholders.  Maybe to avoid any potential conflict in the future on the way to $24 bucks
Comment by ScienceFirst on Mar 03, 2022 8:47pm
Any material will be released through news released.  Even the newsletter. I'm surprised you don't know this after all these years. Nothing to do with TLT.  It's about regulatory rules.  
Comment by ScienceFirst on Mar 03, 2022 8:47pm
Any material will be released through news releases.  Even the newsletter. I'm surprised you don't know this after all these years. Nothing to do with TLT.  It's about regulatory rules.  
Comment by Oilminerdeluxe on Mar 04, 2022 12:51am
I actually called them as well the other day with no reply. But no biggie. Sometimes companies just don't get back to you.
Comment by langosta on Mar 04, 2022 6:14am
Small item: They still don't have photos up of the 'Clinical Trials team', ie Dr Vera and Anita Andoh.. It has been quite a few months now. I see them all sitting around in their little office having their morning 'Tims' and Roger saying, 'Do we have anyone left who knows how to put a photo up on our website?'  Silence, heads shaking.   :-)  
Comment by floatinketucky on Mar 04, 2022 8:01am
Ther is a picture of dr vera on the theralase web site if you need to see her face or something??
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250